Virus

Infectious Disease·MeSH: Virus Diseases

221 drugs in development·66 companies·0 clinical trials

Drug Pipeline by Phase

Approved(15)

Drug	Company
darunavir	Mylan II B.V. (MYL)
ebanga	SAB BIOTHERAPEUTICS, INC. (SABS)
ebanga	Emergent BioSolutions Inc. (EBS)
enflonsia	Merck & Co., Inc. (MRK)
Ervebo	Merck & Co., Inc. (MRK)
etravirine	Amneal Pharmaceuticals, Inc. (AMRX)
fosamprenavir	Mylan II B.V. (MYL)
mavyret	AbbVie Inc. (ABBV)
MAVYRET / MAVIRET	ENANTA PHARMACEUTICALS INC (ENTA)
MAVYRET® / MAVIRET® (glecaprevir/pibrentasvir)	ENANTA PHARMACEUTICALS INC (ENTA)
nevirapine	Mylan II B.V. (MYL)
paxlovid	PFIZER INC (PFE)
Prevymis	Merck & Co., Inc. (MRK)
t-spot.cmv	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
tofidence	BIOGEN INC. (BIIB)

Phase 3(49)

Drug	Company
20vpcv licensed vaccine	Sanofi (SNY)
acne mrna vaccine	Sanofi (SNY)
Afluria® Quadrivalent	Moderna, Inc. (MRNA)
AZM Group	INSMED Inc (INSM)
Bemnifosbuvir-Ruzasvir	Atea Pharmaceuticals, Inc. (AVIR)
bivalent bnt162b2 10 microgram dose	BioNTech SE (BNTX)
bivalent bnt162b2 3 microgram dose	BioNTech SE (BNTX)
bivalent bnt162b2 6 microgram dose	BioNTech SE (BNTX)
Doravirine	Merck & Co., Inc. (MRK)
Emtricitabine/tenofovir disoproxil	Merck & Co., Inc. (MRK)
Fluzone HD	Moderna, Inc. (MRNA)
formulation buffer	NOVAVAX INC (NVAX)
ISL	Merck & Co., Inc. (MRK)
kind-030	Kindred Biosciences, Inc. (KIN)
Live-attenuated CHIKV vaccine VLA1553	Valneva SE (VALN)
MK-8527	Merck & Co., Inc. (MRK)
Molnupiravir	Merck & Co., Inc. (MRK)
mrna-1405	Moderna, Inc. (MRNA)
nirsevimab	ASTRAZENECA PLC (AZN)
nvx-cov2705 vaccine	NOVAVAX INC (NVAX)
palivizumab	ASTRAZENECA PLC (AZN)
pandemic flu h5 mrna vaccine	Sanofi (SNY)
parainfluenza virus type 3 vaccine	Sanofi (SNYNF)
peginterferon lambda	Eiger BioPharmaceuticals, Inc. (EIGR)
posoleucel	Kalaris Therapeutics, Inc. (KLRS)
remestemcel-l	Mesoblast Limited (MESO)
rsv f vaccine with adjuvant	NOVAVAX INC (NVAX)
rsv vaccine formulation 3 dose	Sanofi (SNY)
rsv vaccine formulation 4 dose	Sanofi (SNY)
rsv vaccine formulation 5 dose	Sanofi (SNY)
rsv vaccine formulation 6 dose	Sanofi (SNY)
rsv vaccine formulation 8 dose	Sanofi (SNY)
rsv/hmpv vaccine	Sanofi (SNYNF)
rsv/hmpv vaccine candidate dose a	Sanofi (SNY)
rsv/hmpv vaccine candidate dose b	Sanofi (SNY)
rsv/hmpv vaccine candidate dose l	Sanofi (SNY)
rsv/hmpv/piv3 vaccine	Sanofi (SNY)
rsvt vaccine	Sanofi (SNY)
sim0916	NYMOX PHARMACEUTICAL CORP (NYMXF)
Sofosbuvir-Velpatasvir	Atea Pharmaceuticals, Inc. (AVIR)
Tab-cel (Ebvallo)	Atara Biotherapeutics, Inc. (ATRA)
tabelecleucel	Atara Biotherapeutics, Inc. (ATRA)
ULO	Merck & Co., Inc. (MRK)
Variant-adapted BNT162b2 10 microgram dose	BioNTech SE (BNTX)
Variant-adapted BNT162b2 3 microgram dose	BioNTech SE (BNTX)
Variant-adapted BNT162b2 6 microgram dose	BioNTech SE (BNTX)
VLA1553	Valneva SE (VALN)
VLA1553 full dose	Valneva SE (VALN)
VLA1553 half dose	Valneva SE (VALN)

Phase 2(42)

Drug	Company
2 NRTIs	Merck & Co., Inc. (MRK)
bemnifosbuvir	Atea Pharmaceuticals, Inc. (AVIR)
Bemnifosbuvir	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
BIC/FTC/TAF	Merck & Co., Inc. (MRK)
bivalent norovirus vaccine candidate	Vaxart, Inc. (VXRT)
Celecoxib	UNITED THERAPEUTICS Corp (UTHR)
Clesrovimab	Merck & Co., Inc. (MRK)
Combined LAI Treatment	COLLEGIUM PHARMACEUTICAL, INC (COLL)
daplusiran/tomligisiran	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
dare-hpv	Dare Bioscience, Inc. (DARE)
DOR/3TC/TDF	Merck & Co., Inc. (MRK)
EDP-938	ENANTA PHARMACEUTICALS INC (ENTA)
eseba-vec	HOOKIPA Pharma Inc. (HOOK)
Famotidine	UNITED THERAPEUTICS Corp (UTHR)
FOLFIRI regimen	Crinetics Pharmaceuticals, Inc. (CRNX)
Gardasil 9	Crinetics Pharmaceuticals, Inc. (CRNX)
hh-003	China Health Industries Holdings, Inc. (CHHE)
High dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
High dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
ino-4700	INOVIO PHARMACEUTICALS, INC. (INO)
investigational oral vaccine candidate for covid-19	Vaxart, Inc. (VXRT)
ISL/ULO	Merck & Co., Inc. (MRK)
ivx-121	Icosavax, Inc. (ICVX)
ivx-241	Icosavax, Inc. (ICVX)
lopinavir / ritonavir	Dare Bioscience, Inc. (DARE)
Low dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Low dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Middle dose antigen of LYB005 with A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
Middle dose antigen of LYB005 without A01B adjuvant	Cidara Therapeutics, Inc. (CDTX)
rg6346	Dicerna Pharmaceuticals Inc (DRNA)
rsv vaccine candidate	Sanofi (SNY)
ruzasvir	Atea Pharmaceuticals, Inc. (AVIR)
Ruzasvir	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
sar443122	Sanofi (SNY)
sarilumab sar153191	Sanofi (SNY)
seasonal influenza vaccine candidate	Vaxart, Inc. (VXRT)
taf	China Health Industries Holdings, Inc. (CHHE)
Tobevibart	Xencor Inc (XNCR)
triplex	Fortress Biotech Inc. (FBIO)
triplex	Fortress Biotech Inc. (FBIO)
Vorinostat	UNITED THERAPEUTICS Corp (UTHR)
VTP-200	Barinthus Biotherapeutics plc. (BRNS)

Phase 1(56)

Drug	Company
abi-4334	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-4334 (4334)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
abi-6250	ASSEMBLY BIOSCIENCES, INC. (ASMB)
alvr106	Kalaris Therapeutics, Inc. (KLRS)
CDI-988	Cocrystal Pharma, Inc. (COCP)
ebv vaccine	OPKO HEALTH, INC. (OPK)
EDP-514	ENANTA PHARMACEUTICALS INC (ENTA)
h5 flu imp 10	Sanofi (SNYNF)
h5 flu imp 10	Sanofi (SNY)
h5 flu imp 11	Sanofi (SNY)
h5 flu imp 11	Sanofi (SNYNF)
h5 flu imp 12	Sanofi (SNYNF)
h5 flu imp 12	Sanofi (SNY)
h5 flu imp 2	Sanofi (SNY)
h5 flu imp 2	Sanofi (SNYNF)
h5 flu imp 3	Sanofi (SNYNF)
h5 flu imp 3	Sanofi (SNY)
h5 flu imp 7	Sanofi (SNY)
h5 flu imp 7	Sanofi (SNYNF)
h5 flu imp 8	Sanofi (SNYNF)
h5 flu imp 8	Sanofi (SNY)
h5 flu imp 9	Sanofi (SNY)
h5 flu imp 9	Sanofi (SNYNF)
h5 flu investigational medical product 1	Sanofi (SNYNF)
h5 flu investigational medical product 1	Sanofi (SNY)
hb-500	HOOKIPA Pharma Inc. (HOOK)
hb-502	HOOKIPA Pharma Inc. (HOOK)
hmpv mrna lnp 1	Sanofi (SNY)
hydroxychloroquine sar321068	Sanofi (SNY)
IMC-I109V	Immunocore Holdings plc (IMCR)
MGD014	MACROGENICS INC (MGNX)
MGD014	UNITED THERAPEUTICS Corp (UTHR)
MGD020	MACROGENICS INC (MGNX)
MGD020	UNITED THERAPEUTICS Corp (UTHR)
oravax oral vaccine	ORAMED PHARMACEUTICALS INC. (ORMP)
parainfluenza virus type 3 vaccine	Sanofi (SNY)
Quadrivalent Subunit Influenza Vaccine	Valneva SE (VALN)
rsv imp 4	Sanofi (SNY)
rsv imp 4	Sanofi (SNYNF)
rsv imp 5	Sanofi (SNYNF)
rsv imp 5	Sanofi (SNY)
rsv imp 6	Sanofi (SNY)
rsv imp 6	Sanofi (SNYNF)
rsv mrna lnp 1	Sanofi (SNY)
rsv vaccine 1	Sanofi (SNY)
rsv vaccine 2	Sanofi (SNY)
rsv vaccine formulation 1 dose	Sanofi (SNY)
rsv vaccine formulation 2 dose	Sanofi (SNY)
rsv vaccine formulation 7 dose	Sanofi (SNY)
rsv/hmpv mrna lnp 1	Sanofi (SNY)
rsv/hmpv mrna lnp 2	Sanofi (SNY)
rsv/hmpv vaccine	Sanofi (SNY)
rVSV∆G-MARV-GP	Valneva SE (VALN)
Subunit Influenza Vaccine	Valneva SE (VALN)
vxa g1.1 nn-t	Vaxart, Inc. (VXRT)
vxa g2.4 ns-t	Vaxart, Inc. (VXRT)

Preclinical(18)

Drug	Company
ABI-6250 (6250)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
abi-7272	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ABI-7423 (7423)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
advanced h-plex defense formula 11	HEALTH-RIGHT DISCOVERIES, INC. (HRDV)
alere i tests for sexual health	ALERE INC. (ALR)
AR-201	Aridis Pharmaceuticals, Inc. (ARDS)
at-587	Atea Pharmaceuticals, Inc. (AVIR)
autovac	Orgenesis Inc. (ORGS)
cov	Decoy Therapeutics Inc. (DCOY)
ev-d68 vaccine	GENVEC INC (GNVC)
g103	IMMUNE DESIGN CORP. (IMDZ)
gv2207	GENVEC INC (GNVC)
gv2311	GENVEC INC (GNVC)
h-plex defense	HEALTH-RIGHT DISCOVERIES, INC. (HRDV)
hsv vaccine	MYMETICS CORP (MYMX)
Non-nucleoside polymerase inhibitor (NNPI program)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
rsv vaccine	MYMETICS CORP (MYMX)
sbfm-pl4	SUNSHINE BIOPHARMA INC. (SBFM)

Unknown(10)

Drug	Company
Alinity® m and m2000™	ABBOTT LABORATORIES (ABT)
AVIPure AAV affinity resins (AAV2, AAV8, AAV9, AAV5)	REPLIGEN CORP (RGEN)
AVIPure-AAV9, AVIPure-AAV8, AVIPure-AAV2, AVIPure-AAV5	REPLIGEN CORP (RGEN)
dengue tetravalent vaccine	Sanofi (SNY)
diphenhydramine	Mesoblast Limited (MESO)
livtencity	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
livtencity	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
Recombinant VBP for SARS-CoV-2	AXIM BIOTECHNOLOGIES, INC. (AXIM)
SIUS Gamma	REPLIGEN CORP (RGEN)
vaccine approved for use during pregnancy by the moh	Valneva SE (VALN)

BLA Filed(1)

Drug	Company
bulevirtide	GILEAD SCIENCES, INC. (GILD)

Phase 1/Phase 2(13)

Drug	Company
CYNK-001	Celularity Inc. (CELU)
IMC-M113V	Immunocore Holdings plc (IMCR)
investigational hmpv vaccine	Sanofi (SNY)
investigational hmpv/rsv vaccine	Sanofi (SNY)
investigational rsv vaccine	Sanofi (SNY)
investigational rsv+hmpv vaccine	Sanofi (SNY)
licensed rsv vaccine	Sanofi (SNY)
norovirus gi.1 norwalk virus inoculum	Vaxart, Inc. (VXRT)
rsv vaccine formulation 1	Sanofi (SNY)
rsv vaccine formulation 2	Sanofi (SNY)
vbi-1501	VBI VACCINES INC/BC (VBIV)
vxa-g1.1-nn	Vaxart, Inc. (VXRT)
vxa-g2.4-ns	Vaxart, Inc. (VXRT)

Phase 2/Phase 3(2)

Drug	Company
hil-216	HilleVax, Inc. (HLVX)
PRO 140	CytoDyn Inc. (CYDY)

Phase 4(15)

Drug	Company
bictegravir/emtricitabine/tenofovir alafenamide	GH Research PLC (GHRS)
Control	Valneva SE (VALN)
Control group	Valneva SE (VALN)
High dose potent statin	Cidara Therapeutics, Inc. (CDTX)
mrna-1189	Moderna, Inc. (MRNA)
mRNA-1273.214	Moderna, Inc. (MRNA)
mRNA-1345	Moderna, Inc. (MRNA)
mrna-1403	Moderna, Inc. (MRNA)
mRNA-1647	Moderna, Inc. (MRNA)
mRNA-1893	Moderna, Inc. (MRNA)
nirsevimab	Sanofi (SNY)
nirsevimab respiratory syncytial virus monoclonal antibody	Sanofi (SNY)
Postoperative pain management with acetaminophen	Cidara Therapeutics, Inc. (CDTX)
Postoperative pain management with dexketoprofen	Cidara Therapeutics, Inc. (CDTX)
Postoperative pain management with metamizole	Cidara Therapeutics, Inc. (CDTX)

Compare drugs

darunavir vs ebanga darunavir vs enflonsia darunavir vs Ervebo

Deep-dive into Virus

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis